- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (112)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (630)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (904)
- Research (394)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (606)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Exploring the final frontier to advance cancer research
3 minute read | Published March 08, 2018
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 08, 2018
Kristine Ferrone has survived Mars – or a simulation of the Red Planet, anyway.
During the summer of 2009, Kristine Ferrone and five other volunteers lived for a month in a cramped habitat built on the edge of a 39-million-year-old crater carved out by a meteorite. The barren Canadian island site was about as close as you can get to a Mars-like environment on Earth.
The simulation was an opportunity to conduct geophysical experiments, try out laser therapy to relieve symptoms of physical exertion, and learn about the challenges of minor injuries and illness in such a stark environment.
“This unique simulation experience was the closest mindset to being in space,’’ Ferrone says. “It was invaluable. I go back and draw from it often.”
A chance to curb radiation effects
A third-year doctoral student in our Medical Physics graduate program, Ferrone is conducting research into radiation shielding that she believes could yield benefits for future astronaut pioneers exploring beyond low-Earth orbit, as well as cancer patients here on Earth who are undergoing radiation therapy.
A 10-year NASA veteran, Ferrone has worked as a NASA flight controller for the International Space Station and continues working part-time as a systems engineer for The Aerospace Corporation during her graduate study. In addition to an undergraduate degree in astrophysics, she’s earned three master’s degrees – in space architecture, sports medicine and business administration.
“Human space flight is what I’ve been doing my whole career,’’ she says. “The research I’m doing now aims to reduce the cancer risk for astronauts from space radiation. That’s the end game.’’
Ferrone’s advisors, Charles Willis, Ph.D., associate professor in Imaging Physics, and Stephen Kry, Ph.D., associate professor in Radiation Physics, provide guidance for her dissertation research. Willis, also a former NASA researcher, was one of only three candidates to make the final cut to be an alternate payload specialist astronaut in the late 1980s. Today his career at MD Anderson involves optimizing digital radiography – ultimately to make the best image for our doctors while using the least amount of radiation necessary for our patients. Not unlike the goal of Ferrone’s research.
Tackling a life-threatening environment
Ferrone hopes to be accepted into NASA’s astronaut program one day. She applied in 2008, 2011 and 2016. She expects the addition of a Ph.D. to her qualifications to significantly increase her chances.
To be prepared for any emergency thrown her way, Ferrone volunteers with the Pasadena Fire Department and flies for the Coast Guard Auxiliary. “It keeps me mentally sharp. It would be the same on a space mission: You throw on your gear and go into a life-threatening environment. And it’s fun!”
Would she be game for a trip to the real Mars?
“If I had the chance, I would go,’’ she says. But she realizes there are significant obstacles to human travel to Mars becoming a reality in time for her to have a shot.
Linking space exploration and cancer research
In the meantime, Ferrone hopes her research will one day translate into benefits for space travelers as well as cancer patients.
“It’s pleasantly surprising how many things can translate from MD Anderson-related research to the microcosm of space radiation,” she says. “It takes an oddball person like me to see the connection. But there’s a lot we can learn from each other.”
A longer version of this story originally appeared in Messenger, MD Anderson’s quarterly publication for employees, volunteers, retirees and their families.
Request an appointment at MD Anderson online or by calling 1-877-632-6789.
Related Cancerwise Stories

There’s a lot we can learn from each other.
Kristine Ferrone
Graduate Student